Recruitment unclearEUCTR 2012-004546-15
Assessment of incidence of adverse events in a naive pediatric population treated with an antipsychotic drug over 12 months follow-up
This historical record does not confirm current site availability.
Historical research recordFranceSchizophrenia
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- France
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This is historical registry information. What is the current study status and protocol?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Recruitment unclear
- Enrollment listed in the registry
- 340
- Sponsor
- CHU de Nice
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- France
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2012-004546-15
- Official title
Show the full official title
Assessment of incidence of adverse events in a naive pediatric population treated with an antipsychotic drug over 12 months follow-up
Recruitment & locations
Status unknownThis badge reflects the study status reported by the registry. Check the registry for the latest information.
France
Registry details
Historical country statuses
- France — Not reported
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is CHU de Nice, a hospital or academic medical center.
